Evidence map›Paper›PMID 40208661›Full record

ArticleJMIR public health and surveillance2025

Substance-Related Acute Toxicity Deaths in Canada From 2016 to 2017: Protocol for a Retrospective Chart Review Study of Coroner and Medical Examiner Files.

Jenny Rotondo, Amanda VanSteelandt, Fiona Kouyoumdjian, Matthew J Bowes, Tanya Kakkar, Graham Jones, Brandi Abele, Regan Murray, Emily Schleihauf, Jessica Halverson and 6 more

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Housing status and accidental substance-related acute toxicity deaths in Canada, 2016-2017.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
  4. Chronic pain and accidental acute toxicity deaths in Canada, 2016-2017.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
  5. A comparison of the characteristics of accidental substance-related acute toxicity deaths in Canada across life stages, 2016-2017.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
  6. Article
  7. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  8. Using death investigation data to better understand the overdose crisis.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
  9. Article
  10. Accidental substance-related acute toxicity deaths in older adults in 2016 and 2017: a national chart review study.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jenny RotondoSubstance-Related Harms Division, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0000-0003-4043-5212
Amanda VanSteelandtSubstance-Related Harms Division, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0000-0001-8509-0989
Fiona KouyoumdjianOntario Ministry of Health, Toronto, ON, Canada.ORCID 0000-0002-6869-7516
Matthew J BowesNova Scotia Medical Examiner Service, Department of Justice, Dartmouth, NS, Canada.ORCID 0009-0005-1184-1125
Tanya KakkarSubstance-Related Harms Division, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0009-0003-0842-5249
Graham JonesDepartment of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.ORCID 0009-0006-9816-1508
Brandi AbeleBoard of Directors, Canadian Association of People Who Use Drugs, Saskatoon, SK, Canada.ORCID 0009-0004-7744-3421
Regan MurrayCollaboration on Death Investigation Data, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0000-0002-1031-5407
Emily SchleihaufNova Scotia Medical Examiner Service, Department of Justice, Dartmouth, NS, Canada.ORCID 0000-0001-8418-0050
Jessica HalversonMigration Health Branch, Immigration, Refugees and Citizenship Canada, Ottawa, ON, Canada.ORCID 0009-0009-1376-7255
Jennifer LeasonDepartment of Anthropology and Archaeology, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-3903-7279
Dirk HuyerOffice of the Chief Coroner for Ontario, Ontario Forensic Pathology Service, Toronto, ON, Canada.ORCID 0000-0003-4945-7805
Beth JacksonHealth Equity Policy Division, Strategic Policy Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0009-0003-0265-4841
Songul Bozat-EmreProvincial Information Management and Analytics, Manitoba Health, Winnipeg, MB, Canada.ORCID 0009-0002-9506-499X
Devanshi ShahSubstance-Related Harms Division, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.ORCID 0000-0002-0571-4040
Erin E ReesPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, QC, Canada.ORCID 0000-0002-1886-008X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCanada continues to experience a national overdose crisis. While studies are available at the regional, provincial, and territorial levels, detailed national data regarding the burden and context of substance-related acute toxicity deaths are limited, particularly in subpopulations. In response to the overdose crisis, the Public Health Agency of Canada, in collaboration with provincial and territorial ministries of health and chief coroner and chief medical examiner offices, has undertaken a national chart review study.

objectiveThis study was conducted to describe and compare the characteristics of substance-related acute toxicity deaths that occurred in Canada between 2016 and 2017, including descriptions of those who died, the substances involved, and the circumstances surrounding their deaths. This paper describes the study methodology in detail.

methodsThis retrospective, population-based, and cross-sectional study involved the review of coroner and medical examiner files for deaths that met the study case definition. Data were collected on demographic and socioeconomic characteristics, medical and substance use history, proximal circumstances surrounding the death, and toxicology findings using a standardized data collection tool that underwent 2 pilot studies. Data abstractors underwent training and regular intrarater reliability exercises with a fictitious death investigation file. Data quality was assessed based on the consistency of abstractor intrarater reliability scores and the completeness of core variables and variables for key concepts. Data were linked to national datasets to allow for the examination of area-level geographic and socioeconomic characteristics. Descriptive analyses will examine differences across subpopulations and the general Canadian population. Latent class, spatiotemporal, qualitative, and premature death analyses are also planned. Where possible, analyses will be stratified by the manner of death and sex.

resultsThe study began in the summer of 2018, and abstraction was delayed due to the COVID-19 pandemic. All activities are expected to be completed by early 2025. A total of 9414 coroner and medical examiner files met the study case definition. Most abstractors (25/26, 96%) met the established threshold for consistency throughout abstraction without the need for remedial training. In general, core study variables, including geographic variables and substances contributing to death, had very good availability. Study variables related to the person's health, history of substance use, and events surrounding the acute toxicity event were available for most records. Socioeconomic variables and variables describing socially constructed identities and potentially traumatic life events were mostly unavailable.

conclusionsThis study provides the most detailed national information on substance-related acute toxicity deaths in Canada to date and can serve as a pre-COVID-19 pandemic baseline for assessing the evolution of the overdose crisis. Results can inform policies and programs to address the overdose crisis, the development of common approaches to medicolegal death investigations, and future research activities.

Indexed as

Coroners and Medical ExaminersDrug OverdoseSubstance-Related DisordersAdultCanadaCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesYoung Adultacute toxicityCanadachart review studycoronerdeath investigationsdrug overdosemedical examinermortalitypoisoningprotocol

Identifiers

PMID40208661
PMCPMC12022517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.